002424 Guizhou Bailing Group Pharmaceutical Co.,Ltd.
Closed 01-09 15:00:00
3.69
-0.03
-0.81%
High
3.73
Low
3.67
Vol
10.31M
Open
3.69
D1 Closing
3.72
Amplitude
1.61%
Mkt Cap
5.16B
Tradable Cap
4.48B
Total Shares
1.40B
T/O
38.14M
T/O Rate
0.85%
Tradable Shares
1.21B
P/B
1.49
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%
MT Newswires Live · 2024-11-13
Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%
Load more
Introduction
Company Name.
贵州百灵企业集团制药股份有限公司
Industry:
医药制造业
Listing Date:
2010-06-03
Main Business:
贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的产品主要有银丹心脑通软胶囊、维C银翘片、咳速停糖浆及胶囊、小儿柴桂退热颗粒、金感胶囊、双羊喉痹通颗粒、泌淋清胶囊、康妇灵胶囊、复方一枝黄花喷雾剂、经带宁胶囊、消咳颗粒、糖宁通络胶囊/片、肥料、纯净水。凭借良好的科技创新能力和突出的知识产权优势,公司被认定为“2023年新确定的国家知识产权示范企业”。
Issue price:
40.00
{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.","latestPrice":3.69,"timestamp":1736406183000,"preClose":3.72,"halted":0,"volume":10312000,"delay":0,"changeRate":-0.0081,"floatShares":1213000000,"shares":1398000000,"eps":-0.334,"marketStatus":"Closed","change":-0.03,"latestTime":"01-09 15:00:00","open":3.69,"high":3.73,"low":3.67,"amount":38139100,"amplitude":0.0161,"askPrice":3.7,"askSize":4432,"bidPrice":3.69,"bidSize":1594,"shortable":0,"etf":0,"ttmEps":-0.334,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1736472600000},"marketStatusCode":5,"adr":0,"adjPreClose":3.72,"symbolType":"stock","openAndCloseTimeList":[[1736386200000,1736393400000],[1736398800000,1736406000000]],"highLimit":3.91,"lowLimit":3.53,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1397598400,"isCdr":false,"pbRate":1.49,"roa":"--","roe":"2.55%","epsLYR":-0.3,"committee":0.080971,"marketValue":5157000000,"turnoverRate":0.0085,"status":1,"floatMarketCap":4477000000},"requestUrl":"/m/hq/s/002424","defaultTab":"news","newsList":[{"id":"2483418680","title":"Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483418680","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483418680?lang=en_us&edition=fundamental","pubTime":"2024-11-13 13:59","pubTimestamp":1731477555,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved Guizhou Bailing Group Pharmaceutical unit Bailing Yuxiu Pharmaceutical's clinical trials for its diabetic retinopathy tablets, according to a Wednesday filing with the Shenzhen Stock Exchange.The Tangning Tongluo traditional Chinese medicine tablets are indicated for non-proliferative diabetic retinopathy, as well as Yin deficiency, internal heat, and eye network stasis, the report said.Shares rose 5% during Wednesday's trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0028","BK0146","BK0188","BK0183","BK0077","002424"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","stockEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":-0.0934},{"period":"3month","weight":0.0885},{"period":"6month","weight":0.1604},{"period":"1year","weight":-0.5317},{"period":"ytd","weight":-0.0416}],"companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","perCapita":"14395股","boardName":"医药制造业","registeredCapital":"139759万元","compareEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.002},{"period":"6month","weight":0.0808},{"period":"1year","weight":0.116},{"period":"ytd","weight":-0.0419}],"survey":" 贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的产品主要有银丹心脑通软胶囊、维C银翘片、咳速停糖浆及胶囊、小儿柴桂退热颗粒、金感胶囊、双羊喉痹通颗粒、泌淋清胶囊、康妇灵胶囊、复方一枝黄花喷雾剂、经带宁胶囊、消咳颗粒、糖宁通络胶囊/片、肥料、纯净水。凭借良好的科技创新能力和突出的知识产权优势,公司被认定为“2023年新确定的国家知识产权示范企业”。","serverTime":1736464533637,"listedPrice":40,"stockholders":"84279人(较上一季度减少0.83%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.,002424,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票老虎,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票老虎国际,Guizhou Bailing Group Pharmaceutical Co.,Ltd.行情,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票行情,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股价,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股市,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票价格,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票交易,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票购买,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}